Advertisement
U.S. markets close in 45 minutes

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
71.27-1.63 (-2.24%)
As of 03:15PM EST. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/28/2024
Current
12/31/20239/30/20236/30/20233/31/202312/31/2022
Market Cap (intraday)
7.06B6.89B5.01B6.08B5.18B5.01B
Enterprise Value
6.58B6.42B4.51B5.56B4.61B4.41B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/A526.32N/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
15.1216.3613.6019.3920.4425.65
Price/Book (mrq)
11.9311.498.269.697.907.32
Enterprise Value/Revenue
14.2348.8035.8550.5248.6650.43
Enterprise Value/EBITDA
-41.40-188.95-152.50-118.24-95.51-93.28

Trading Information

Stock Price History

Beta (5Y Monthly) 1.04
52-Week Change 347.81%
S&P500 52-Week Change 328.52%
52 Week High 376.11
52 Week Low 342.01
50-Day Moving Average 369.29
200-Day Moving Average 361.10

Share Statistics

Avg Vol (3 month) 3887.21k
Avg Vol (10 day) 3971.75k
Shares Outstanding 596.81M
Implied Shares Outstanding 696.81M
Float 894.64M
% Held by Insiders 12.60%
% Held by Institutions 198.58%
Shares Short (Feb 15, 2024) 43.86M
Short Ratio (Feb 15, 2024) 44.51
Short % of Float (Feb 15, 2024) 44.65%
Short % of Shares Outstanding (Feb 15, 2024) 44.00%
Shares Short (prior month Jan 12, 2024) 43.51M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -30.08%
Operating Margin (ttm)-25.81%

Management Effectiveness

Return on Assets (ttm)-13.43%
Return on Equity (ttm)-22.39%

Income Statement

Revenue (ttm)464.37M
Revenue Per Share (ttm)4.84
Quarterly Revenue Growth (yoy)50.30%
Gross Profit (ttm)N/A
EBITDA -158.85M
Net Income Avi to Common (ttm)-139.67M
Diluted EPS (ttm)-1.46
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)497.94M
Total Cash Per Share (mrq)5.14
Total Debt (mrq)16.94M
Total Debt/Equity (mrq)2.86%
Current Ratio (mrq)5.41
Book Value Per Share (mrq)6.14

Cash Flow Statement

Operating Cash Flow (ttm)-124.2M
Levered Free Cash Flow (ttm)-28.97M